Pharmaceutical Sciences

Doctor of Philosophy

The Doctor of Philosophy program requires the completion of 30 semester credits of letter-graded course work with a GPA of 3.0 or better. Of the 30 credits, at least 18 credits must be at 700 level. Candidates defend their dissertations. Candidates for the Ph.D. will be required to take an examination directed at determining competency in the pharmaceutical sciences.

The department requires the following core courses:

Core Courses
BIOC 701Comprehensive Biochemistry I4
BIOC 702Comprehensive Biochemistry II4
PSCI 611Principles of Pharmacokinetics and Pharmacodynamics3
PSCI 670Pharmacokinetics3
STAT 725Applied Statistics3
Additional Credits7 (minimum)
Courses numbered 700-789, 791
Seminars
Graduate Seminar (one credit each semester)
Research60
Doctoral Dissertation
Total Credits90

Master of Science

In consultation with the adviser and student's supervisory committee a Plan of Study would be developed. The Master of Science in Pharmaceutical Sciences program follows Graduate College degree requirements.

Amanda Brooks, Ph.D.
University of Wyoming, 2006
Postdoctoral: University of California San Diego, 2006-2007; University of Utah, 2008-2010
Assistant Research Professor, 2011-2014
Research interests: Biomimetics, Recombinant Protein Expression for Biomedical Devices, Controlled Drug Delivery to Combat Antibiotic Resistance

Yagna Jarajapu, M.Pharm., Ph.D.
University of Strathclyde, 1998
Glasgow Caledonian University, 2002
Postdoctoral: University of Florida and Wake Forest University 2003-2008
Research Interests: ACE2/Angiotensin-(1-7) and Bone Marrow Progenitor Cells in Diabetes

Estelle Leclerc, Ph.D.
University Paris XI, 1994
Postdoctoral: ETH-Zurich, 1994-1998; The Scripps Research Institute, 1998-2003
Junior Group Leader Children's Hospital Zurich, 2004
Research Assistant Professor Florida Atlantic University, 2005-2009
Research Interests: Biopharmaceutics

Sanku Mallik, Ph.D.
Case Western Reserve University, 1992
Postdoctoral: California Institute of Technology, 1993-95
Research Interests: Synthetic medicinal chemistry

Stephen T. O'Rourke, Ph.D.
University of Wisconsin, 1985
Postdoctoral: Mayo Clinic and Foundation, 1985-87
Research Interests: Vascular Pharmacology

Steven Qian, Ph.D.
The University of Iowa, 1999
Postdoctoral: National Institute of Environmental Health Science (NIEHS, NIH) 2000-2004
Research Interests: Roles of Lipid Derived and Protein-Derived Free Radical Metabolites in All Kinds of Health Related Problems

Jagdish Singh, Ph.D.
Banaras Hindu University, 1982
Postdoctoral: University of Otago, New Zealand, 1985-88; University of California--San Francisco, 1992-94
Research Interests: Novel Dosage and Drug Delivery Systems, Biopharmaceutics

Kristine Steffen, Pharm.D., Ph.D.
North Dakota State University, 2002
North Dakota State University, 2007
Postdoctoral: Neuropsychiatric Research Institute, 2007-2009
Research Interests: Pharmacokinetics, Bariatric Surgery, Eating Disorder and Obesity Pharmacotherapy

Chengwen Sun, M.D., Ph.D.
Norman Bethune University of Medical Sciences, 1988
Norman Bethune University of Medical Sciences, 1996
Postdoctoral: Department of Physiology, Medical College of Wisconsin, 1996-2000
Research Interests: Central Blood Pressure Control and Hypertension Gene Therapy

Sathish Venkatachalem, Ph.D.
University of Madras, 2003
Postdoctoral: University of Western Ontario, 2004-2006
Research Interests: Human Lung Diseases (Asthma, Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension)

Stefan Vetter, Ph.D.
Swiss Institute of Technology (ETH) Zurich,1998
Postdoctoral: The Scripps Research Institute, 2000-2005
Research Interest: Medicinal Protein Biochemistry